15,000 Shares in Sema4 Holdings Corp (NASDAQ:SMFR) Acquired by Deltec Asset Management LLC

Deltec Asset Management LLC bought a new position in Sema4 Holdings Corp (NASDAQ:SMFR) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund bought 15,000 shares of the company’s stock, valued at approximately $114,000.

Separately, Marshall Wace LLP acquired a new stake in Sema4 in the 2nd quarter worth approximately $28,559,000. 74.08% of the stock is owned by institutional investors.

SMFR opened at $6.76 on Thursday. Sema4 Holdings Corp has a 1 year low of $6.30 and a 1 year high of $27.18. The company’s 50 day moving average price is $7.91.

Sema4 (NASDAQ:SMFR) last released its quarterly earnings data on Monday, November 15th. The company reported $0.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.19) by $0.34. The firm had revenue of $43.18 million for the quarter, compared to the consensus estimate of $42.00 million. On average, analysts predict that Sema4 Holdings Corp will post -0.55 EPS for the current year.

SMFR has been the subject of several analyst reports. Zacks Investment Research lowered Sema4 from a “hold” rating to a “sell” rating in a report on Thursday. BTIG Research initiated coverage on Sema4 in a report on Friday, October 8th. They issued a “buy” rating and a $12.00 target price for the company. The Goldman Sachs Group began coverage on Sema4 in a report on Friday, November 19th. They issued a “buy” rating and a $12.00 target price for the company. Jefferies Financial Group began coverage on Sema4 in a research report on Friday, September 24th. They issued a “buy” rating and a $13.00 price target on the stock. Finally, Cowen began coverage on Sema4 in a research report on Thursday, September 30th. They issued an “outperform” rating and a $13.00 price target on the stock. One analyst has rated the stock with a sell rating and four have issued a buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Buy” and a consensus price target of $12.50.

In other Sema4 news, CFO Isaac Ro sold 40,848 shares of the company’s stock in a transaction on Monday, October 25th. The stock was sold at an average price of $7.54, for a total value of $307,993.92. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, COO James Coffin sold 5,752 shares of the company’s stock in a transaction on Monday, October 25th. The shares were sold at an average price of $7.54, for a total value of $43,370.08. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 105,438 shares of company stock worth $815,461.

About Sema4

Sema4 Holdings Corp is a patient-centered health intelligence company. It is transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. Sema4 Holdings Corp, formerly known as CM Life Sciences, is based in STAMFORD, Conn.

See Also: 12b-1 Fees

Institutional Ownership by Quarter for Sema4 (NASDAQ:SMFR)

Receive News & Ratings for Sema4 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sema4 and related companies with MarketBeat.com's FREE daily email newsletter.